FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of iktos

image description

Iktos and Zealand Pharma to Develop Artificial Intelligence Technology for Peptide Drug Design

Collaboration leverages Iktos’ capabilities in machine learning and AI and Zealand expertise in peptide drug discovery

23-Jun-2022 - Iktos, a company specialized in Artificial Intelligence for new drug design, announced a research collaboration with Zealand Pharma A/S, a biotechnology company changing lives with innovative peptide-based medicines to co-develop generative and predictive AI technologies for peptide drug ...

artificial intelligence drug design drug discovery +1
image description

French start-up Iktos announces a collaboration with Ono in artificial intelligence for new drug design

Rapid identification of molecules that simultaneously satisfy multiple parameters, such as potency, selectivity, safety, and project-specific properties

05-Apr-2022 - Iktos, a company specialized in Artificial Intelligence (AI) for new drug design announced a collaboration agreement with Ono Pharmaceuticals Co., Ltd., a leading pharmaceutical company based in Japan with a focus on innovative medicines dedicated to the fight against disease and pain. Under the ...

artificial intelligence drug design drug discovery
image description

Iktos Announces Collaboration With Pfizer in AI for Drug Design

“We are proud to work with Pfizer and to have their scientists use our software in their early discovery programs”

03-Mar-2021 - Iktos announced the application of Iktos Artificial Intelligence technology for de novo design to selected Pfizer small-molecule discovery programs. Over the last few years, phenomenal advances in AI algorithmic development and computational power have enabled innovative approaches in ...

artificial intelligence drug discovery small molecule drugs

Merck cooperates with French start-up

Generative modelling AI technology enables rapid and cost-effective design of novel drugs

15-Mar-2019 - Merck announced a collaboration agreement with Iktos, for the use of its generative modelling artificial intelligence (AI) technology, in order to facilitate the rapid and cost-effective discovery and design of promising new compounds. “This agreement is another illustration of how we aim to ...

artificial intelligence drug design drug discovery